Latest Conference Articles

CPHI Annual Report: VC Capital Investment and Contract Services Growth in 2024

CPHI Annual Report: VC Capital Investment and Contract Services Growth in 2024

October 24th 2023

The report indicates a rise in biotech funding and subsequent growth for pharma contract services.

Bettersize Unveils New Capabilities at AAPS 2023 PharmSci 360

Bettersize Unveils New Capabilities at AAPS 2023 PharmSci 360

October 24th 2023

Bettersize US showcases their BeNano Series, Bettersizer 2600, and BetterPyc 380 instruments at the AAPS 2023 PharmSci 360 event.

Crucial Points from a Manufacturing Perspective (PDA/FDA Joint Regulatory Conference 2023)

Crucial Points from a Manufacturing Perspective (PDA/FDA Joint Regulatory Conference 2023)

October 17th 2023

Conference

Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the important components of nitrosamine impurities from a manufacturing point of view as a part of his session, "Reducing Nitrosamines Without the Use of Scavengers: The Critical Role of Excipients - An Excipient Manufacturer's View."

The Recent Discoveries of Nitrosamine Impurities (PDA/FDA Joint Regulatory Conference 2023)

The Recent Discoveries of Nitrosamine Impurities (PDA/FDA Joint Regulatory Conference 2023)

October 16th 2023

Conference

Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the recent findings of nitrosamine impurities in human drugs as a part of his session, "Reducing Nitrosamines Without the Use of Scavengers: The Critical Role of Excipients - An Excipient Manufacturer's View."

Innovative Start-Ups at CPHI Barcelona

Innovative Start-Ups at CPHI Barcelona

October 15th 2023

The Start-Up Market at CPHI Barcelona will bring together 27 start-ups, innovators, and small enterprises from across the pharma landscape.

Welcome to CPHI Barcelona

Welcome to CPHI Barcelona

October 15th 2023

Sherma Ellis Daal, brand director, Pharma at Informa Markets, gives a preview of CPHI Barcelona 2023.

The Impact of AI on Pharma

The Impact of AI on Pharma

October 15th 2023

CPHI’s Annual Report predicts huge impact of AI on drug development and manufacturing.

Global Cell Therapy Requirements Need Thorough Understanding

Global Cell Therapy Requirements Need Thorough Understanding

October 13th 2023

Conference

Humberto Vega, PhD, Executive Director, Bristol Myers Squibb, discusses the requirements needed to be successful in global cell therapy as a part of his session, "Successfully Navigating Global Cell Therapy Requirements."

The Challenges of the Journey from Clinical to Commercial Cell Therapies

The Challenges of the Journey from Clinical to Commercial Cell Therapies

October 12th 2023

Conference

Humberto Vega, PhD, Executive Director, Bristol Myers Squibb, discusses the journey from clinical to commercial cell therapies as a part of his session, "Successfully Navigating Global Cell Therapy Requirements."

Highlighting CAR-T as an Important Modality (PDA/FDA Joint Regulatory Conference 2023)

Highlighting CAR-T as an Important Modality (PDA/FDA Joint Regulatory Conference 2023)

October 11th 2023

Conference

Bassem Gayed, PhD, Senior Technical Director of CAR-T Process Engineering, Manufacturing Science & Technology at Bristol Myers Squibb, discusses the importance of CAR-T as a modality.